SEC Form 4 · accession 0001193125-26-259529
Beam Therapeutics Inc. · BEAM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christi Shaw
Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001745999
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $29.55 | Jun 3, 2026 | A | 19,676 | A | — | Jun 3, 2036 | Common Stock | 19,676 | 19,676 | D |
Explanation of responses
- F1The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.